← Back to Search

Behavioural Intervention

Augmented Reality for Pediatric Cardiac Arrest

N/A
Waitlist Available
Led By Johan N Siebert, MD, PD
Research Sponsored by Johan Siebert, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have prior basic life support training
Be older than 18 years old
Must not have
Unable to perform tasks required of the role
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the use of augmented reality devices to the traditional AHA pocket reference card in pediatric emergency departments to see if it helps healthcare teams follow advanced life support guidelines better and reduce medication errors during

Who is the study for?
This trial is for healthcare teams in pediatric emergency departments. Participants must be able to perform cardiopulmonary resuscitation (CPR) and use either augmented reality tools or a pocket reference card during simulated cardiac arrest scenarios.
What is being tested?
The study compares the effectiveness of an augmented reality tool versus a conventional AHA pocket reference card during CPR. It measures adherence to guidelines, performance, and medication errors in pediatric cardiac arrest situations.
What are the potential side effects?
Since this trial involves simulation training with no direct patient interventions, there are no medical side effects expected from participating. However, participants may experience stress or fatigue due to the nature of emergency simulations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have completed basic life support training.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to perform certain required tasks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to first dose of epinephrine
Secondary study objectives
Cardiopulmonary resuscitation quality: Chest compression fraction
Cardiopulmonary resuscitation quality: Percentage of overall excellent cardiopulmonary resuscitation
Cardiopulmonary resuscitation quality: Peri-shock pause duration
+16 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (Augmented Reality)Experimental Treatment1 Intervention
Participants that will use the augmented reality supportive tool during the simulation-based pediatric scenario.
Group II: Arm B (Conventional methods)Active Control1 Intervention
Participants that will use conventional methods during the simulation-based pediatric scenario.

Find a Location

Who is running the clinical trial?

Johan Siebert, MDLead Sponsor
Geneva Children's Hospital, Geneva, SwitzerlandUNKNOWN
Alberta Children's Hospital, Calgary, CanadaUNKNOWN
~47 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top